NCT02385968

Brief Summary

The aim is to investigate if herniated nucleus material in lumbar disc herniations is infected with bacteria, and if so, to determine their prevalence (control group), and to determine if patients with pre-existing Modic changes type 1 have a higher incidence of bacterial growth in relevant lumbar disc samples than patients without Modic changes. A cohort of 15 patients with pre-existing Modic and 15 without-undergoing primary surgery will be examined.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2014

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 11, 2015

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

July 30, 2024

Status Verified

July 1, 2024

Enrollment Period

1 year

First QC Date

March 4, 2015

Last Update Submit

July 26, 2024

Conditions

Keywords

ModicMicrobiologyImmunology

Outcome Measures

Primary Outcomes (1)

  • Bacterial growth on a per-patient basis

    at time of surgery

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient with MRI-confirmed lumbar disc herniation. Lumbar disc herniation. Age between 18 and 65 years. No prior spine surgery. No diagnosed dementia.

You may qualify if:

  • MRI-confirmed lumbar disc herniation.
  • Age between 18 and 65 years.
  • No prior spine surgery.
  • No diagnosed dementia.

You may not qualify if:

  • Antibiotic treatment within the previous two weeks.
  • History of alcohol abuse, illicit drug use or drug abuse, or significant mental illness
  • Known immune deficiency state (e.g., positive for human immunodeficiency virus) or in treatment with immunosuppressive drugs including high dose steroids or cyclosporine.
  • Concurrent infections (infections of skin, urinary tract infection, other skin diseases, e.g. Acne vulgaris).
  • Previous epidural instrumentation.
  • Uncontrolled, unstable or recently diagnosed autoimmune disease, including but not limited to systemic lupus erythematosus, inflammatory bowel disease, sarcoidosis, rheumatoid arthritis, or psoriasis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Middelfart Spinesurgery research department

Middelfart, Region Syddanmark, 5500, Denmark

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Biopsies of Nucleus

MeSH Terms

Conditions

Intervertebral Disc Displacement

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Karen H. Hansen

    Sygehus Lillebaelt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research nurse

Study Record Dates

First Submitted

March 4, 2015

First Posted

March 11, 2015

Study Start

October 1, 2014

Primary Completion

October 1, 2015

Study Completion

October 1, 2016

Last Updated

July 30, 2024

Record last verified: 2024-07

Locations